This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access Genotropin® (somatropin, rbe) prescribing information and adverse event reporting can be found at the bottom of the page.

The Genotropin MiniQuick Device

MiniQuick

The Genotropin MiniQuick contains a single dose of somatropin growth hormone and is a discreet, portable, single use device. It’s small and simple to use, and doesn’t have to be stored in a fridge before the growth hormone is mixed, making it ideal for use when away from home or travelling.

Benefits for patients and healthcare professionals1-3:

  • Pre-filled and disposable
  • Four simple steps ease training and everyday use
  • Safety pen needles with built in needle cover for discreet dose delivery are available

Easy to use
  • Single fixed dose – no dose setting required, reducing risk of incorrect dosing
  • Available in 10 different strengths (0.2 – 2mg)
  • Provides simplicity for the patient, combined with dosage accuracy for the healthcare professional

Precise pre-filled doses
  • Can be stored at or below 25°C by the end user for up to 6 months
  • After reconstitution, can be stored in a refrigerator (2–8°C) for up to 24 hours
  • Packaged in a 7-day supply to simplify therapy

No refrigeration required
  • Young adults going to college or university
  • Patients with learning difficulties
  • Patients who speak a different language
  • Where compliance issues are anticipated
  • Working life involves time away from home
  • Holiday or travel limits access to fridge

Suitable for a range of patients ​​​​​​​
  • Does not contain preservatives

Preservative-free

Storage

Although the Genotropin MiniQuick does not need to be stored in a fridge prior to mixing, patients should be instructed that if the MiniQuick is not going to be used immediately, it must be stored in a fridge and used within a 24 hour period.

Explore more

MiniQuick dosing and demonstration

Watch how a child patient takes Genotropin with the Miniquick device

Find out more

Starter kits

A choice of personalised starter kits is available to child and adult Genotropin patients to make sure they get off to a good start with their treatment

Find out more
References
  1. ​​​​​​​Genotropin Summary of product characteristics. Accessed here 
  2. PACKAGE LEAFLET: INFORMATION FOR THE USER. GENOTROPIN® 5.3 mg and 12 mg powder and solvent for solution for injection. Accessed here 
  3. Pfizer data on file, Horizon Research & Consulting, 2011. MiniQuick Switch/Preference Study
PP-GEN-GBR-0741. March 2021

The GoQuick

Find out more about the GoQuick device

Visit the GoQuick page

The Pen

Find out more about the Pen device

Visit the Pen page

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No